PROPOSED ISSUE TO RAISE UP TO £150,000

                                                                                                                                                          18 March 2013


                                                        SUTHERLAND HEALTH GROUP PLC
                                            (“Sutherland Health Group” or “the Company”)
                                                                     ISDX Symbol: SHGP


                                                 PROPOSED ISSUE TO RAISE UP TO £150,000


The Directors of Sutherland Health Group are pleased to announce that they are proposing to raise up to £150,000 of additional working capital to enable the Company to further progress its business strategy. The Directors propose to raise the funds through the issue of up to 12,000,000 new Ordinary Shares at a price of 1.25p per share to existing shareholders and Investment Professionals as defined in the Financial
Services Markets Act 2000 (Financial Promotion) Order 2005 (the “Offer”).


Further details of the Offer are contained in an Executive Summary which was posted to shareholders in the Company. A copy of the Executive Summary will be available from the Company’s website www.sutherlandhealth.com and www.isdx.com. The salient features of the Offer are:-

  • The new Ordinary Shares are being offered at 1.25p
  • The minimum subscription for new Ordinary Shares is £1000, and thereafter in any multiples       £1000.
  • The new Ordinary Shares are eligible for EIS and IHT relief.
  • Completed Applications must be received by Neville Registrars by 3pm Thursday 4th April 2013


Although the opportunity of taking up the Offer is being made available to existing Shareholders in the Company and to Investment Professionals, it is not being done on a pre-emptive basis, i.e. shareholders and potential investors may apply for as much or as little of the new issue of Ordinary Shares (subject to the conditions of issue) as they wish.


The net proceeds of the new Ordinary Shares (expected to be £142,000 assuming full subscription) will be used by the Company for working capital purposes and to accelerate the sales, marketing and business development activities. In addition to a planned increase in distribution of its current product range, there is a new product development programme already underway, and the Company is currently active in exploring
opportunities to work closely with complementary organisations and will also seek out compatible acquisition opportunities only when appropriate.


Shareholders and potential investors should note that the Executive Summary containing details of the Offer is not a prospectus for the offer of securities to the public and as a consequence may not contain all of the details which you might expect to see in a prospectus. The Executive Summary has not been verified to the same standards or accuracy as a prospectus.


The Directors are currently interested in 30,272,517 Ordinary Shares representing approximately 43.4 per cent of the Company’s issued share capital.


                                                                                ---ENDS---


The Directors of the Issuer accept responsibility for this announcement
Enquiries:

Sutherland Health Group Plc
John French, Chairman
E: john@sutherlandhealth.com
T: 07836 722482


Peterhouse Corporate Finance Limited
Heena Karani
E: heena@pcorpfin.com
T: 0207 469 0930


Bishopsgate Communications Ltd
Maxine Barnes
E: shg@bishopsgatecommunications.com
T: 0207 562 3367
M: 07860 489571


Notes to Editors:
Sutherland Health Group Plc is a national supplier of patient hygiene, sexual health and diagnostic products to the UK National Health Service (NHS) and other UK customers. Its aim is to supply innovative solutions to current health issues by studying current trends and working alongside leading professionals who also work within the health sector.


The company is committed to developing and marketing high quality brands and products that will benefit health professionals and consumers alike in many areas of health. The Group has established its own brands: Condomania® Condoms; Sutherland® Patient Hygiene and Personal Care; Lubricating Jelly; and Vision® pregnancy and gynaecology diagnostics. These products have already become established within the NHS business.


The Group is ISO and MHRA registered, and at present principally manufactures and operates within the United Kingdom.


For further information on the Company visit www.sutherlandhealth.com
 

Latest news RSS

09/11/2017

Sutherland at Procurex Wales 2017

Sutherland at Procurex Wales 2017

29/06/2017

Final Results 30th September 2016

Sutherland Health Group Final Results September 2016

11/11/2016

Sutherland Attending European Midwives Conference

Sutherland Attending EMA Conference

Sign up

Subscribe

For further information, please read our Privacy Policy.